Protection against simian/human immunodeficiency virus (SHIV) 89.6P in macaques after coimmunization with SHIV antigen and IL-15 plasmid

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Proceedings of the National Academy of Sciences of the United States of America

• Publication date

  2007-11-20

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1073/pnas.0709198104PMID 18000037PMCID PMC2141831
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Highly attenuated rabies virus-based vaccine vectors expressing simian-human immunodeficiency virus89.6P Env and simian immunodeficiency virusmac239 Gag are safe in rhesus macaques and protect from an AIDS-like disease.

  2007cited by this paper
• Diagnosis of the small round blue cell tumors using multiplex polymerase chain reaction.

  2007cited by this paper
• A Replication-Competent Adenovirus-Human Immunodeficiency Virus (Ad-HIV) tat and Ad-HIV env Priming/Tat and Envelope Protein Boosting Regimen Elicits Enhanced Protective Efficacy against Simian/Human Immunodeficiency Virus SHIV89.6P Challenge in Rhesus Macaques

  2007cited by this paper
• Comparative ability of plasmid IL-12 and IL-15 to enhance cellular and humoral immune responses elicited by a SIVgag plasmid DNA vaccine and alter disease progression following SHIV(89.6P) challenge in rhesus macaques.

  2007cited by this paper
• Preserved CD4+ Central Memory T Cells and Survival in Vaccinated SIV-Challenged Monkeys

  2006cited by this paper
• A dose sparing effect by plasmid encoded IL-12 adjuvant on a SIVgag-plasmid DNA vaccine in rhesus macaques.

  2006cited by this paper
• Immunogenicity of Heterologous Recombinant Adenovirus Prime-Boost Vaccine Regimens Is Enhanced by Circumventing Vector Cross-Reactivity

  2006cited by this paper
• Initiation of antiretroviral therapy during chronic SIV infection leads to rapid reduction in viral loads and the level of T‐cell immune response

  2006cited by this paper
• Studies on GM-CSF DNA as an adjuvant for neutralizing Ab elicited by a DNA/MVA immunodeficiency virus vaccine.

  2006cited by this paper
• SIV DNA vaccine co‐administered with IL‐12 expression plasmid enhances CD8 SIV cellular immune responses in cynomolgus macaques

  2005cited by this paper
• Coimmunization with an Optimized IL-15 Plasmid Results in Enhanced Function and Longevity of CD8 T Cells That Are Partially Independent of CD4 T Cell Help3

  2005cited by this paper
• Attenuation of Simian Immunodeficiency Virus SIVmac239 Infection by Prophylactic Immunization with DNA and Recombinant Adenoviral Vaccine Vectors Expressing Gag

  2005cited by this paper
• Novel Adeno-Associated Virus Vector Vaccine Restricts Replication of Simian Immunodeficiency Virus in Macaques

  2005cited by this paper
• Avipox-based simian immunodeficiency virus (SIV) vaccines elicit a high frequency of SIV-specific CD4+ and CD8+ T-cell responses in vaccinia-experienced SIVmac251-infected macaques.

  2004cited by this paper
• A Novel Approach for Producing Lentiviruses That Are Limited to a Single Cycle of Infection

  2004cited by this paper
• Progress towards the use of Listeria monocytogenes as a live bacterial vaccine vector for the delivery of HIV antigens

  2004cited by this paper
• Cytotoxic T Lymphocyte–based Control of Simian Immunodeficiency Virus Replication in a Preclinical AIDS Vaccine Trial

  2004cited by this paper
• IL-15/IL-15Ralpha-mediated avidity maturation of memory CD8+ T cells.

  2004cited by this paper
• Heterologous Envelope Immunogens Contribute to AIDS Vaccine Protection in Rhesus Monkeys

  2004cited by this paper
• An SHIV DNA/MVA Rectal Vaccination in Macaques Provides Systemic and Mucosal Virus-Specific Responses and Protection against AIDS

  2004cited by this paper
• Vaccine protection from CD4+ T-cell loss caused by simian immunodeficiency virus (SIV) mac251 is afforded by sequential immunization with three unrelated vaccine vectors encoding multiple SIV antigens.

  2004cited by this paper
• Antigen-independent memory CD8 T cells do not develop during chronic viral infection.

  2004cited by this paper
• Immunogenicity of Recombinant Adenovirus Serotype 35 Vaccine in the Presence of Pre-Existing Anti-Ad5 Immunity1

  2004cited by this paper
• Immunogenicity of Attenuated Vesicular Stomatitis Virus Vectors Expressing HIV Type 1 Env and SIV Gag Proteins: Comparison of Intranasal and Intramuscular Vaccination Routes

  2004cited by this paper
• Enhanced cellular immunity and systemic control of SHIV infection by combined parenteral and mucosal administration of a DNA prime MVA boost vaccine regimen.

  2004cited by this paper
• A human immunodeficiency virus 1 (HIV-1) clade A vaccine in clinical trials: stimulation of HIV-specific T-cell responses by DNA and recombinant modified vaccinia virus Ankara (MVA) vaccines in humans.

  2004cited by this paper
• IL-15/IL-15Rα-mediated avidity maturation of memory CD8 + T cells

  2004cited by this paper
• Coadministration of HIV vaccine vectors with vaccinia viruses expressing IL-15 but not IL-2 induces long-lasting cellular immunity

  2003cited by this paper
• HIV-1 Viremia Prevents the Establishment of Interleukin 2–producing HIV-specific Memory CD4+ T Cells Endowed with Proliferative Capacity

  2003cited by this paper
• Turnover of memory-phenotype CD8+ T cells.

  2003cited by this paper
• Lineage relationship and protective immunity of memory CD8 T cell subsets

  2003cited by this paper
• Immunogenicity in pig-tailed macaques of poliovirus replicons expressing HIV-1 and SIV antigens and protection against SHIV-89.6P disease.

  2003cited by this paper
• Outcome of Simian-Human Immunodeficiency Virus Strain 89.6p Challenge following Vaccination of Rhesus Macaques with Human Immunodeficiency Virus Tat Protein

  2002cited by this paper
• The contrasting roles of IL-2 and IL-15 in the life and death of lymphocytes: implications for the immunotherapy of rheumatological diseases

  2002cited by this paper
• Effects of Antigen and Genetic Adjuvants on Immune Responses to Human Immunodeficiency Virus DNA Vaccines in Mice

  2002cited by this paper
• Activity of matrix metalloproteinase‐9 is elevated in sera of patients with systemic lupus erythematosus

  2002cited by this paper
• Molecular and functional profiling of memory CD8 T cell differentiation.

  2002cited by this paper
• Interleukin 15 Is Required for Proliferative Renewal of Virus-specific Memory CD8 T Cells

  2002cited by this paper
• Identification of a Novel Posttranscriptional Regulatory Element by Using a rev- and RRE-Mutated Human Immunodeficiency Virus Type 1 DNA Proviral Clone as a Molecular Trap

  2001cited by this paper
• Supplement Review

  2001cited by this paper
• Modulation of Cellular Responses by Plasmid CD40L: CD40L Plasmid Vectors Enhance Antigen-Specific Helper T Cell Type 1 CD4+ T Cell-Mediated Protective Immunity against Herpes Simplex Virus Type 2 in Vivo

  2001cited by this paper
• Vaccination of seronegative volunteers with a human immunodeficiency virus type 1 env/rev DNA vaccine induces antigen-specific proliferation and lymphocyte production of beta-chemokines.

  2000cited by this paper
• Augmentation of immune responses to HIV-1 and simian immunodeficiency virus DNA vaccines by IL-2/Ig plasmid administration in rhesus monkeys.

  2000cited by this paper
• Correlation of metalloproteinase-2 and -9 with proinflammatory cytokines interleukin-1ß, interleukin-12 and the interleukin-1 receptor antagonist in patients with chronic uveitis

  2000cited by this paper
• Control of homeostasis of CD8+ memory T cells by opposing cytokines.

  2000cited by this paper
• DNA vaccination: antigen presentation and the induction of immunity

  2000cited by this paper
• Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination.

  2000cited by this paper
• Enhancement of cellular immune response in HIV-1 seropositive individuals: A DNA-based trial.

  1999cited by this paper
• Broadly cross-reactive HIV-specific cytotoxic T-lymphocytes in highly-exposed persistently seronegative donors.

  1999cited by this paper
• IL-12 gene as a DNA vaccine adjuvant in a herpes mouse model: IL-12 enhances Th1-type CD4+ T cell-mediated protective immunity against herpes simplex virus-2 challenge.

  1999cited by this paper
• Modulation of amplitude and direction of in vivo immune responses by co‐administration of cytokine gene expression cassettes with DNA immunogens

  1998cited by this paper
• Interleukin-2, interleukin-15, and their receptors.

  1998cited by this paper
• CD8 positive T cells influence antigen-specific immune responses through the expression of chemokines.

  1998cited by this paper
• Matrix metalloproteinase (MMP)-9 type IV collagenase/gelatinase implicated in the pathogenesis of Sjögren's syndrome.

  1998cited by this paper
• First human trial of a DNA-based vaccine for treatment of human immunodeficiency virus type 1 infection: safety and host response.

  1998cited by this paper
• Potent and selective stimulation of memory-phenotype CD8+ T cells in vivo by IL-15.

  1998cited by this paper
• Cellular cytotoxic response induced by DNA vaccination in HIV-1-infected patients.

  1998cited by this paper
• Engineering of in vivo immune responses to DNA immunization via codelivery of costimulatory molecule genes

  1997cited by this paper
• Development of a multicomponent candidate vaccine for HIV-1.

  1997cited by this paper
• A molecularly cloned, pathogenic, neutralization-resistant simian immunodeficiency virus, SIVsmE543-3

  1997cited by this paper
• In vivo engineering of a cellular immune response by coadministration of IL-12 expression vector with a DNA immunogen.

  1997cited by this paper
• Cytotoxic T-lymphocyte cross-reactivity among different human immunodeficiency virus type 1 clades: implications for vaccine development

  1997cited by this paper
• Expression of matrix metalloproteinase 9 (96-kd gelatinase B) in human rheumatoid arthritis.

  1996cited by this paper
• Errata

  1995cited by this paper
• HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women

  1995cited by this paper
• High levels of anti-human immunodeficiency virus type 1 (HIV-1) memory cytotoxic T-lymphocyte activity and low viral load are associated with lack of disease in HIV-1-infected long-term nonprogressors

  1995cited by this paper
• Cloning of a T cell growth factor that interacts with the beta chain of the interleukin-2 receptor.

  1994cited by this paper
• Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome

  1994cited by this paper
• HIV-specific cytotoxic T-cell activity in an HIV-exposed but uninfected infant.

  1993cited by this paper

• Immunomodulation with IL-7 and IL-15 in HIV-1 infection

  2023cites this paper
• The impact of MDSCs on the efficacy of preventive and therapeutic HIV vaccines.

  2021cites this paper
• Therapeutic Potential of IL-15 and N-803 in HIV/SIV Infection

  2021cites this paper
• The Key Role of Nucleic Acid Vaccines for One Health

  2021cites this paper
• Therapeutic Vaccines for the Treatment of HIV.

  2020cites this paper
• Mucosal Vaccine Approaches for Prevention of HIV and SIV Transmission.

  2019cites this paper
• Monkey Models and HIV Vaccine Research.

  2018cites this paper
• ALT-803 Transiently Reduces Simian Immunodeficiency Virus Replication in the Absence of Antiretroviral Treatment

  2017cites this paper
• Advancements in DNA vaccine vectors, non-mechanical delivery methods, and molecular adjuvants to increase immunogenicity

  2017cites this paper
• The catalytic A1 domains of cholera toxin and heat-labile enterotoxin are potent DNA adjuvants that evoke mixed Th1/Th17 cellular immune responses

  2015cites this paper
• Regulatory T Cells Modulate DNA Vaccine Immunogenicity at Early Time via Functional CD4+ T Cells and Antigen Duration

  2015cites this paper
• Immunité et protection induites par un lentivecteur ADN innovant chez les modèles animaux de vaccination VIH-1.

  2015cites this paper
• A novel non-integrative single-cycle chimeric HIV lentivector DNA vaccine.

  2015cites this paper
• Strategies for Improving Vaccines to Elicit T Cells to Treat Cancer

  2015cites this paper
• Immunogenicity of a novel enhanced consensus DNA vaccine encoding the leptospiral protein LipL45

  2015cites this paper
• Configuration-dependent Presentation of Multivalent IL-15:IL-15Rα Enhances the Antigen-specific T Cell Response and Anti-tumor Immunity*

  2015cites this paper
• Progress in the development of vaccines for hepatitis C virus infection.

  2015cites this paper
• HIV DNA Vaccine: Stepwise Improvements Make a Difference

  2014cites this paper
• T cell interleukin-15 surface expression in chimpanzees infected with human immunodeficiency virus.

  2014cites this paper
• Downregulation of endogenous STAT3 augments tumoricidal activity of interleukin 15 activated dendritic cell against lymphoma and leukemia via TRAIL.

  2014cites this paper
• Vaccine-induced myeloid cell population dampens protective immunity to SIV.

  2014cites this paper
• Co-Administration of Molecular Adjuvants Expressing NF-Kappa B Subunit p65/RelA or Type-1 Transactivator T-bet Enhance Antigen Specific DNA Vaccine-Induced Immunity

  2014cites this paper
• A novel real‐time CTL assay to measure designer T‐cell function against HIV Env+ cells

  2014cites this paper
• DNA vaccination by intradermal electroporation induces long-lasting immune responses in rhesus macaques

  2014cites this paper
• Nonstructural Protein 2 (nsP2) of Chikungunya Virus (CHIKV) Enhances Protective Immunity Mediated by a CHIKV Envelope Protein Expressing DNA Vaccine

  2013cites this paper
• HIV-1 Env DNA Vaccine plus Protein Boost Delivered by EP Expands B- and T-Cell Responses and Neutralizing Phenotype In Vivo

  2013cites this paper
• Vaccination with Vaxfectin® adjuvanted SIV DNA induces long-lasting humoral immune responses able to reduce SIVmac251 Viremia

  2013cites this paper
• The current state of tuberculosis vaccines

  2013cites this paper
• 51 – Human immunodeficiency virus vaccines

  2013cites this paper
• DNA and virus particle vaccination protects against acquisition and confers control of viremia upon heterologous simian immunodeficiency virus challenge

  2013cites this paper
• Infectious Diseases & Therapy Immunotherapy in HIV Infection

  2013cites this paper
• Nucleic Acid Vaccines

  2013cites this paper
• ADVANCES IN DNA VACCINES AGAINST INFECTIOUS DISEASES

  2013cites this paper
• Plasmodium inui infection reduces the efficacy of a simian immunodeficiency virus DNA vaccine in a rhesus macaque model through alteration of the vaccine-induced immune response.

  2012cites this paper
• Safety and Immunogenicity of an HIV-1 Gag DNA Vaccine with or without IL-12 and/or IL-15 Plasmid Cytokine Adjuvant in Healthy, HIV-1 Uninfected Adults

  2012cites this paper
• Genetic Variants in Arhgef11 Are Associated With Kidney Injury in the Dahl Salt-Sensitive Rat

  2012cites this paper
• Large intestine-targeted nanoparticle-releasing oral vaccine to control genitorectal viral infection

  2012cites this paper
• Influence of Cytokines on HIV-Specific Antibody-Dependent Cellular Cytotoxicity Activation Profile of Natural Killer Cells

  2012cites this paper
• DNA-based HIV vaccines do not induce generalized activation in mucosal tissue T cells

  2012cites this paper
• Cytokine production and dysregulation in HIV pathogenesis: lessons for development of therapeutics and vaccines.

  2012cites this paper
• Regulating the immune system via IL-15 transpresentation.

  2012cites this paper
• IL-12 DNA as molecular vaccine adjuvant increases the cytotoxic T cell responses and breadth of humoral immune responses in SIV DNA vaccinated macaques

  2012cites this paper
• Functions of IL-15 in anti-viral immunity: multiplicity and variety.

  2012cites this paper
• A push-pull vaccine strategy using Toll-like receptor ligands, IL-15, and blockade of negative regulation to improve the quality and quantity of T cell immune responses.

  2012cites this paper
• Molecular adjuvant HMGB1 enhances anti-influenza immunity during DNA vaccination

  2011cites this paper
• TLR agonists and/or IL-15 adjuvanted mucosal SIV vaccine reduced gut CD4⁺ memory T cell loss in SIVmac251-challenged rhesus macaques.

  2011cites this paper
• The Cytokine Network of Acute HIV Infection: A Promising Target for Vaccines and Therapy to Reduce Viral Set-Point?

  2011cites this paper
• Immunotherapeutic restoration in HIV-infected individuals.

  2011cites this paper
• Role of IL-15 in immune-mediated and infectious diseases.

  2011cites this paper
• Strategies to enhance the potency of HIV-1 DNA vaccines

  2011cites this paper
• GENETIC IMMUNIZATION IN THE HORSE: THE POTENTIAL FOR ENHANCED IMMUNE RESPONSES WITH DEACYLATED POLYETHYLENEIMINE (PEI) AND IMMUNOSTIMULATORY CYTOKINES AS VACCINE ADJUVANTS

  2011cites this paper
• Vaccination for hepatitis C virus: closing in on an evasive target

  2011cites this paper
• Comparison of immune responses generated by optimized DNA vaccination against SIV antigens in mice and macaques.

  2011cites this paper
• Specific Pathogen-Free Status Alters Immunophenotype in Rhesus Macaques: Implications for the Study of Simian Immunodeficiency Virus

  2011cites this paper
• An Anti-HIV-1 V3 Loop Antibody Fully Protects Cross-Clade and Elicits T-Cell Immunity in Macaques Mucosally Challenged with an R5 Clade C SHIV

  2011cites this paper
• A DNA Vaccine against Chikungunya Virus Is Protective in Mice and Induces Neutralizing Antibodies in Mice and Nonhuman Primates

  2011cites this paper
• Human immunodeficiency virus (HIV) immunopathogenesis and vaccine development: a review.

  2011cites this paper
• Human Immunodeficiency Virus and Leishmaniasis

  2010cites this paper
• Innate and adaptive immune correlates of vaccine and adjuvant-induced control of mucosal transmission of SIV in macaques

  2010cites this paper
• Chikungunya: A Potentially Emerging Epidemic?

  2010cites this paper
• Phase 1 Safety and Immunogenicity Evaluation of ADVAX, a Multigenic, DNA-Based Clade C/B' HIV-1 Candidate Vaccine

  2010cites this paper
• Adjuvant activity of cytokines.

  2010cites this paper
• Using 3 TLR ligands as a combination adjuvant induces qualitative changes in T cell responses needed for antiviral protection in mice.

  2010cites this paper
• Title Phase I safety and immunogenicity evaluation of ADVAX , aMultigenic , DNA-based Clade C / B ' HIV-1 candidate vaccine

  2010cites this paper
• Designing immunity to HIV: manipulating antibody-dependent cellular cytotoxicity antibodies

  2009cites this paper
• High dose of plasmid IL-15 inhibits immune responses in an influenza non-human primates immunogenicity model.

  2009cites this paper
• Obstacles to the successful development of an efficacious T cell‐inducing HIV‐1 vaccine

  2009cites this paper
• Plasmid-Encoded Interleukin-15 Receptor α Enhances Specific Immune Responses Induced by a DNA Vaccine In Vivo

  2009cites this paper
• CD8+ Cell Depletion of SHIV89.6P-Infected Macaques Induces CD4+ T Cell Proliferation that Contributes to Increased Viral Loads1

  2009cites this paper
• Contributes to Increased Viral Loads T Cell Proliferation + Macaques Induces CD 4 Cell Depletion of SHIV 89 . 6 P-Infected + CD 8

  2009influential citation
• DNA vaccine therapy for chronic hepatitis C virus (HCV) infection: immune control of a moving target

  2009cites this paper
• Immunotherapy of viral infections.

  2009cites this paper
• Induction of granulysin in CD8+ T cells by IL‐21 and IL‐15 is suppressed by human immunodeficiency virus‐1

  2009cites this paper
• Co‐immunization with an optimized plasmid‐encoded immune stimulatory interleukin, high‐mobility group box 1 protein, results in enhanced interferon‐γ secretion by antigen‐specific CD8 T cells

  2009cites this paper
• Technical transformation of biodefense vaccines.

  2009cites this paper
• Co-immunization with IL-15 enhances cellular immune responses induced by a vif-deleted simian immunodeficiency virus proviral DNA vaccine and confers partial protection against vaginal challenge with SIVmac251.

  2009cites this paper
• IL-2, IL-7 and IL-15 as immuno-modulators during SIV/HIV vaccination and treatment.

  2009cites this paper
• Mucosal prior to systemic application of recombinant adenovirus boosting is more immunogenic than systemic application twice but confers similar protection against SIV-challenge in DNA vaccine-primed macaques.

  2009cites this paper
• [Vaccines for the future].

  2009cites this paper
• Role of IL-15 and IL-21 in viral immunity: applications for vaccines and therapies

  2009cites this paper
• Immunogenicity of novel consensus-based DNA vaccines against Chikungunya virus.

  2008cites this paper
• Otimização da resposta de células T CD8+ de memória ao herpes simplex virus-1 utilizando terapia genética com interleucina-15 e interleucina-21

  2008cites this paper
• Manipulation of the bluetongue virus tubules for immunogen delivery.

  2008cites this paper
• Special Topic: Progress and Challenges in Vaccinology HIV/AIDS Vaccines: A Need for New Concepts?

  2008cites this paper
• Evaluation of dual-serotype adenovirus-based vaccine-induced cellular immunity following preventative and therapeutic immunization against simian immunodeficiency virus

  2008cites this paper
• Quantitative Multiplexed Gene Expression: An Analysis of Sensitivity, Accuracy and Precision

  2008cites this paper
• Sequential Priming with Simian Immunodeficiency Virus (SIV) DNA Vaccines, with or without Encoded Cytokines, and a Replicating Adenovirus-SIV Recombinant Followed by Protein Boosting Does Not Control a Pathogenic SIVmac251 Mucosal Challenge

  2008cites this paper
• Efficient augmentation of a long-lasting immune responses in HIV-1 gag DNA vaccination by IL-15 plasmid boosting.

  2008cites this paper
• Cytokines as adjuvants for improving anti-HIV responses

  2008cites this paper
• DNA vaccines: developing new strategies to enhance immune responses

  2008cites this paper
• Sustained suppression of SHIV89.6P replication in macaques by vaccine-induced CD8+ memory T cells

  2008cites this paper
• HIV-1 Vaccine Development : Recent Advances in the CTL Platform “ Spotty Business ”

  2007cites this paper
• Human Immunodeficiency Virus Type 1 Vaccine Development: Recent Advances in the Cytotoxic T-Lymphocyte Platform “Spotty Business”

  2007cites this paper